High Volume Regulated Device
Invetech co-developed the initial concept and presented it to our client as a potential new product for their business. A considerable amount of competing intellectual property existed but none had been successfully commercialized. Based on encouraging market feedback our client decided to fully develop the product including concurrent development of the automated assembly system for high volume production.
- Bayer Australia
- Concurrent development of an innovative product and automated assembly machine for a high volume regulated device.
Working closely with our client's marketing and manufacturing teams, we created:
- A revolutionary regulated product and associated IP,
- A new automated, high volume production system to get the new product to market, quickly and reliably.
Focusing on our client's commercial goals, we collaborated with their marketing team to ensure the end product would maximise the consumer experience and deliver value to their brand.
The world-first closure was designed to suit automated, current Good Manufacturing Practices (cGMP) assembly and filling on custom-designed equipment in a Therapeutic Goods Administration (TGA) certified facility.
Invetech designed and built the high volume manufacturing system to comply with regulatory requirements including pharmaceutical grade manufacturing and packaging. The product is assembled using fully automated production equipment with a range of in-built inspection processes to ensure the highest quality.
In addition, our team actively managed the product's transfer to production by working closely with their component suppliers and preferred contract manufacturer throughout the development process.
Our team delivered a first-of-kind regulated device enabling our client to launch a new product category into a saturated consumer market.